JP2022530615A5 - - Google Patents
Info
- Publication number
- JP2022530615A5 JP2022530615A5 JP2021562389A JP2021562389A JP2022530615A5 JP 2022530615 A5 JP2022530615 A5 JP 2022530615A5 JP 2021562389 A JP2021562389 A JP 2021562389A JP 2021562389 A JP2021562389 A JP 2021562389A JP 2022530615 A5 JP2022530615 A5 JP 2022530615A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic preparation
- patient
- preparation according
- fviii
- factor viii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962843221P | 2019-05-03 | 2019-05-03 | |
| US62/843,221 | 2019-05-03 | ||
| US201962845209P | 2019-05-08 | 2019-05-08 | |
| US62/845,209 | 2019-05-08 | ||
| PCT/US2020/031197 WO2020227162A1 (en) | 2019-05-03 | 2020-05-01 | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530615A JP2022530615A (ja) | 2022-06-30 |
| JP2022530615A5 true JP2022530615A5 (enExample) | 2023-05-08 |
| JP7692363B2 JP7692363B2 (ja) | 2025-06-13 |
Family
ID=73050863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562389A Active JP7692363B2 (ja) | 2019-05-03 | 2020-05-01 | 嚥下可能な薬物送達デバイスを使用する腸管の組織への送達のための凝固因子調製物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220118056A1 (enExample) |
| EP (1) | EP3962516B1 (enExample) |
| JP (1) | JP7692363B2 (enExample) |
| KR (1) | KR20220004148A (enExample) |
| CN (1) | CN114007638A (enExample) |
| AU (1) | AU2020270420B2 (enExample) |
| BR (1) | BR112021021904A2 (enExample) |
| CA (1) | CA3137539A1 (enExample) |
| MX (1) | MX2021013310A (enExample) |
| WO (1) | WO2020227162A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8562589B2 (en) | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| CA3082043A1 (en) | 2017-11-07 | 2019-05-16 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
| EP3937971A4 (en) * | 2019-03-13 | 2022-12-14 | Rani Therapeutics, LLC | THERAPEUTIC AGENT PREPARATIONS AND METHODS OF DRUG DELIVERY INTO AN INTESTINAL TRACT Lumen USING A SWALLOWED DRUG DELIVERY DEVICE |
| JP2024508396A (ja) * | 2021-02-24 | 2024-02-27 | ラニ セラピューティクス， エルエルシー | 血友病ａの治療 |
| JP2024513983A (ja) * | 2021-04-13 | 2024-03-27 | グリフォルス・ワールドワイド・オペレーションズ・リミテッド | 第ｖｉｉｉ因子または第ｖｉｉｉ因子／フォン・ヴィレブランド因子複合体を含む液体組成物 |
| CN115300774B (zh) * | 2022-08-27 | 2024-01-30 | 深圳市资福医疗技术有限公司 | 一种药剂递送装置、释药方法及应用其的释药胶囊 |
| CN118221797B (zh) * | 2024-04-28 | 2025-02-18 | 内蒙古工业大学 | 一种具有脱敏效果的乳球蛋白肽及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| ATE141646T1 (de) | 1986-04-09 | 1996-09-15 | Genzyme Corp | Genetisch transformierte tiere, die ein gewünschtes protein in milch absondern |
| FR2619314B1 (fr) | 1987-08-11 | 1990-06-15 | Transgene Sa | Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant |
| AT405517B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
| US8562589B2 (en) * | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
| JP5931757B2 (ja) * | 2010-03-10 | 2016-06-08 | インキューブ ラブズ， エルエルシー | 嚥下可能な薬物送達デバイスを用いた腸管の内腔への送達のための治療薬調製物 |
| US9149617B2 (en) * | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8734429B2 (en) * | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) * | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2012282875B2 (en) * | 2011-07-08 | 2016-04-21 | Bioverativ Therapeutics Inc. | Factor VIII chimeric and hybrid polypeptides, and methods of use thereof |
| US20140019297A1 (en) * | 2012-07-10 | 2014-01-16 | Bootic, Inc. | Electronic Commerce System Incorporating Shopping Baskets |
| US11548940B2 (en) * | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) * | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| EP3288543A4 (en) * | 2015-05-01 | 2018-11-14 | Incube Labs, LLC | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| AU2016320867B2 (en) * | 2015-09-08 | 2023-03-30 | Rani Therapeutics, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| JP6877469B2 (ja) * | 2016-06-24 | 2021-05-26 | モガム・インスティテュート・フォー・バイオメディカル・リサーチＭｏｇａｍ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂｉｏｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ | Ｆｖｉｉｉおよびｖｗｆ因子を含むキメラタンパク質、ならびにそれらの使用 |
| CN106279437B (zh) * | 2016-08-19 | 2017-10-31 | 安源医药科技（上海）有限公司 | 高糖基化人凝血因子viii融合蛋白及其制备方法与用途 |
| MX2019006444A (es) * | 2016-12-02 | 2019-10-30 | Bioverativ Therapeutics Inc | Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos. |
| CA3082043A1 (en) * | 2017-11-07 | 2019-05-16 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
-
2020
- 2020-05-01 KR KR1020217038935A patent/KR20220004148A/ko active Pending
- 2020-05-01 CA CA3137539A patent/CA3137539A1/en active Pending
- 2020-05-01 WO PCT/US2020/031197 patent/WO2020227162A1/en not_active Ceased
- 2020-05-01 MX MX2021013310A patent/MX2021013310A/es unknown
- 2020-05-01 EP EP20801591.7A patent/EP3962516B1/en active Active
- 2020-05-01 AU AU2020270420A patent/AU2020270420B2/en active Active
- 2020-05-01 CN CN202080047333.3A patent/CN114007638A/zh active Pending
- 2020-05-01 JP JP2021562389A patent/JP7692363B2/ja active Active
- 2020-05-01 BR BR112021021904A patent/BR112021021904A2/pt unknown
-
2021
- 2021-10-29 US US17/515,284 patent/US20220118056A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6616914B2 (en) | Method for pulmonary and oral delivery of pharmaceuticals | |
| ES2260916T3 (es) | Preparacion en polvo para administracion a traves de la mucosa que contiene una medicina polimerica. | |
| JP2704019B2 (ja) | 薬剤含有マトリックス | |
| RU2002127804A (ru) | Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения | |
| CN101287457B (zh) | Treprostinil用于治疗神经性糖尿病的足部溃疡的用途 | |
| JP2022009125A5 (enExample) | ||
| CA2066403A1 (en) | Transmucosal dosage form | |
| JP2003515533A5 (enExample) | ||
| JP2002500180A5 (enExample) | ||
| JP2022524446A5 (enExample) | ||
| JP2005533021A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| RU2002118115A (ru) | Препаративная форма стабильного водного раствора интерферона, способ ее приготовления и использования | |
| CN105380941A (zh) | 苯酞类化合物药物用途及其医药组合物 | |
| JP2007508284A5 (enExample) | ||
| CN103977010B (zh) | 一种犬用复方赛拉嗪注射剂及其制备方法 | |
| JP2008266179A (ja) | 経肺用組成物 | |
| JP2012532852A (ja) | ２型糖尿病における食後高血糖の経頬粘膜治療の方法、および当該治療に用いられる医薬組成物 | |
| CN103664936A (zh) | 一类治疗创伤性脑损伤疾病的化合物及其用途 | |
| WO2001080895A3 (en) | Methods and compositions for the treatment of cardiac indications | |
| CN104758304B (zh) | 三七皂苷r1的医药用途 | |
| Ament et al. | Cardiac Arrest During Anesthesia: A Review of Cases | |
| Neustein et al. | Cardiovascular consequences of the concomitant administration of nifedipine and magnesium sulfate in pigs | |
| JP2011510962A (ja) | トリプタンの経口腔粘膜投与用製剤形態 | |
| JP2012512851A (ja) | セトロンを頬側経粘膜投与するための処方物（ｆｏｒｍｕｌａｔｉｏｎ） |